AI assistant
METLIFE INC — Director's Dealing 2020
Feb 28, 2020
29995_dirs_2020-02-27_8d72fe30-a196-4861-bd0d-b84af986d9bc.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: METLIFE INC (MET)
CIK: 0001099219
Period of Report: 2020-02-25
Reporting Person: Khalaf Michel (Director, President & CEO)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2020-02-25 | Common Stock | A | 17558 | — | Acquired | 40138 | Direct |
| 2020-02-25 | Common Stock | D | 17558 | $47.58 | Disposed | 22580 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2020-02-25 | Employee Stock Options (right to buy) | $47.58 | A | 94578 | Acquired | 2030-02-24 | Common Stock (94578.0) | Direct |
| 2020-02-25 | Restricted Stock Units | $ | A | 31526 | Acquired | Common Stock (31526.0) | Direct |
Footnotes
F1: Cash payout of 2017-2019 performance units, following determination of the performance factor for such award. Each performance unit is settled in cash equal to the closing price of one share of MetLife, Inc. common stock on the payout date.
F2: The options become exercisable in equal installments on each of the first three anniversaries of the grant date.
F3: Each restricted stock unit is the contingent right to receive one share of MetLife, Inc. common stock.
F4: The restricted stock units vest in substantially equal installments on the first business day in March following each of the first three anniversaries of the grant date.